CME Group Inc (NASDAQ:CME) insider Julie Winkler sold 2,457 shares of the firm’s stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $150.41, for a total transaction of $369,557.37. Following the completion of the transaction, the insider now directly owns 16,318 shares in the company, valued at approximately $2,454,390.38. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Shares of CME Group Inc (NASDAQ CME) traded up $0.75 during mid-day trading on Monday, reaching $152.82. 1,493,900 shares of the company’s stock traded hands, compared to its average volume of 1,373,500. The firm has a market cap of $51,823.55, a price-to-earnings ratio of 31.97, a P/E/G ratio of 3.14 and a beta of 0.73. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05. CME Group Inc has a 52 week low of $113.27 and a 52 week high of $155.29.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million during the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the business earned $1.05 EPS. equities research analysts predict that CME Group Inc will post 4.78 earnings per share for the current fiscal year.

The business also recently disclosed a None dividend, which will be paid on Monday, January 15th. Shareholders of record on Thursday, December 28th will be issued a dividend of $3.50 per share. The ex-dividend date of this dividend is Wednesday, December 27th. CME Group’s dividend payout ratio is currently 59.86%.

A number of hedge funds have recently made changes to their positions in the business. Hudock Capital Group LLC grew its holdings in CME Group by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock worth $487,000 after acquiring an additional 20 shares in the last quarter. Ropes Wealth Advisors LLC grew its holdings in CME Group by 0.4% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 10,801 shares of the financial services provider’s stock worth $1,353,000 after acquiring an additional 38 shares in the last quarter. Pitcairn Co. grew its holdings in CME Group by 2.2% during the 2nd quarter. Pitcairn Co. now owns 3,317 shares of the financial services provider’s stock worth $416,000 after acquiring an additional 70 shares in the last quarter. IFP Advisors Inc grew its holdings in CME Group by 2.4% during the 2nd quarter. IFP Advisors Inc now owns 2,998 shares of the financial services provider’s stock worth $375,000 after acquiring an additional 71 shares in the last quarter. Finally, Bronfman E.L. Rothschild L.P. lifted its position in shares of CME Group by 4.7% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,876 shares of the financial services provider’s stock worth $235,000 after buying an additional 85 shares during the last quarter. 83.17% of the stock is owned by institutional investors.

A number of brokerages have recently commented on CME. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Citigroup raised their price target on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, October 19th. Barclays assumed coverage on shares of CME Group in a report on Friday, September 8th. They set an “overweight” rating and a $139.00 price target for the company. Wells Fargo & Company raised their price target on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 4th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $133.00 price target on shares of CME Group in a report on Thursday, September 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company’s stock. CME Group currently has an average rating of “Buy” and an average price target of $141.75.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/11/cme-group-inc-cme-insider-sells-369557-37-in-stock.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.